Company profile: Daxor
1.1 - Company Overview
Company description
- Provider of medical instrumentation and biotechnology solutions, offering the BVA-100 diagnostic blood test that quantifies blood volume status and composition to aid management of medical and surgical conditions, and clinical education and support for effective use of the BVA-100 in clinical settings.
Products and services
- BVA-100: A diagnostic blood test quantifying blood volume status and composition, aiding management of various medical and surgical conditions in clinical settings
- BVA-100 System: Referenced system for clinical use of the diagnostic blood test that quantifies blood volume status and composition, aiding management of medical and surgical conditions
- Clinical Education and Support: Daxor offers educational resources and support for effective use of the BVA-100 system in clinical settings
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Daxor
Shield Therapeutics
HQ: United Kingdom
Website
- Description: Provider of late-stage, mineral-derived hospital pharmaceuticals addressing areas of high unmet medical need, focused on development and commercialization. Offers ACCRUFER, an oral therapy for adults with iron deficiency with or without anemia, and drug safety services monitoring and addressing the safety of patients using its products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Shield Therapeutics company profile →
Accumetrics
HQ: United States
Website
- Description: Provider of the VerifyNow System, a comprehensive suite of assays for assessing platelet function, which the company develops, manufactures, and markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accumetrics company profile →
Hemerus
HQ: United States
Website
- Description: Provider of technologies for the collection, processing, preservation and storage of blood and blood products, including the SOLX System for whole blood collection and leukoreduction with preparation of red blood cells and plasma from blood held at room temperature for up to 24 hours; LEUP leukoreduction processing circuits enabling single-step, ventless processing; and LEUKOSEP leukocyte reduction filters with minimal residual hold-up.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemerus company profile →
Biomaneo
HQ: France
Website
- Description: Provider of medical analysis kits for the detailed analysis of proteins by mass spectrometry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomaneo company profile →
Vitestro
HQ: The Netherlands
Website
- Description: Provider of autonomous blood drawing technology: an AI-based, ultrasound-guided robotic device that automates blood collection from tourniquet application to bandage placement; Vitestro Academy training for healthcare professionals on safe use and workflows; and the A.D.O.P.T. trial evaluating performance and safety in 10,000+ patients toward CE marking by end of 2024.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vitestro company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Daxor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Daxor
2.2 - Growth funds investing in similar companies to Daxor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Daxor
4.2 - Public trading comparable groups for Daxor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →